[1]. Ball N, Teo WP, Chandra S, Chapman J. Parkinson's Disease and the Environment. Front Neurol. 2019 10: 218.
[2]. Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016 15: 1257-1272.
[3]. Pouchieu C, Piel C, Carles C, et al. Pesticide use in agriculture and Parkinson's disease in the AGRICAN cohort study. Int J Epidemiol. 2018 47: 299-310.
[4]. Paul KC, Sinsheimer JS, Cockburn M, Bronstein JM, Bordelon Y, Ritz B. Organophosphate pesticides and PON1 L55M in Parkinson's disease progression. Environ Int. 2017 107: 75-81.
[5]. Kaur K, Kaur R. Occupational Pesticide Exposure, Impaired DNA Repair, and Diseases. Indian J Occup Environ Med. 2018 22: 74-81.
[6]. Gamache PL, Haj Salem I, Roux-Dubois N, Le Bouthillier J, Gan-Or Z, Dupre N. Exposure to Pesticides and Welding Hastens the Age-at-Onset of Parkinson's Disease. Can J Neurol Sci. 2019: 1-6.
[7]. Caballero M, Amiri S, Denney JT, Monsivais P, Hystad P, Amram O. Estimated Residential Exposure to Agricultural Chemicals and Premature Mortality by Parkinson's Disease in Washington State. Int J Environ Res Public Health. 2018 15.
[8]. Fernandes GC, Socal MP, Schuh AF, Rieder CR. Clinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort. Parkinsons Dis. 2015 2015: 959304.
[9]. Coelho FEA, Lopes LC, Cavalcante RMS, Correa GC, Leduc A. Brazil unwisely gives pesticides a free pass. Science. 2019 365: 552-553.
[10]. Rieck M, Schumacher-Schuh AF, Altmann V, et al. DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients. Pharmacogenomics. 2012 13: 1701-1710.
[11]. https://www.falecidosnobrasil.org.br/ (accessed July 1, 2019 2019).
[12]. Lamarca R, Alonso J, Gomez G, Munoz A. Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci. 1998 53: M337-343.
[13]. Caudle WM. Occupational exposures and parkinsonism. Handb Clin Neurol. 2015 131: 225-239.
[14]. Nandipati S, Litvan I. Environmental Exposures and Parkinson's Disease. Int J Environ Res Public Health. 2016 13.
[15]. Tanner CM, Ross GW, Jewell SA, et al. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol. 2009 66: 1106-1113.
[16]. Gunnarsson LG, Bodin L. Parkinson's disease and occupational exposures: a systematic literature review and meta-analyses. Scand J Work Environ Health. 2017 43: 197-209.
[17]. Yan D, Zhang Y, Liu L, Shi N, Yan H. Pesticide exposure and risk of Parkinson's disease: Dose-response meta-analysis of observational studies. Regul Toxicol Pharmacol. 2018 96: 57-63.
[18]. Krueger PM, Tran MK, Hummer RA, Chang VW. Mortality Attributable to Low Levels of Education in the United States. PLoS One. 2015 10: e0131809.
[19]. Rogers RG, Everett BG, Zajacova A, Hummer RA. Educational degrees and adult mortality risk in the United States. Biodemography Soc Biol. 2010 56: 80-99.
[20]. Sichieri R, de Lolio CA, Correia VR, Everhart JE. Geographical patterns of proportionate mortality for the most common causes of death in Brazil. Rev Saude Publica. 1992 26: 424-430.
[21]. Rogot E, Sorlie PD, Johnson NJ. Life expectancy by employment status, income, and education in the National Longitudinal Mortality Study. Public Health Rep. 1992 107: 457-461.
[22]. Yang F, Johansson AL, Pedersen NL, Fang F, Gatz M, Wirdefeldt K. Socioeconomic status in relation to Parkinson's disease risk and mortality: A population-based prospective study. Medicine (Baltimore). 2016 95: e4337.
[23]. Beard JD, Steege AL, Ju J, Lu J, Luckhaupt SE, Schubauer-Berigan MK. Mortality from Amyotrophic Lateral Sclerosis and Parkinson's Disease Among Different Occupation Groups - United States, 1985-2011. MMWR Morb Mortal Wkly Rep. 2017 66: 718-722.
[24]. Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis. 2010 20 Suppl 1: S221-238.
[25]. Palacios N, Gao X, McCullough ML, et al. Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord. 2012 27: 1276-1282.
[26]. Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener. 2017 6: 18.
[27]. Betensky RA, Mandel M. Recognizing the problem of delayed entry in time-to-event studies: Better late than never for clinical neuroscientists. Ann Neurol. 2015 78: 839-844.